Skip to main content
Clinical Trials/NCT00903669
NCT00903669
Completed
Not Applicable

Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial Paralysis

University of Campinas, Brazil1 site in 1 country20 target enrollmentJanuary 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Facial Paralysis
Sponsor
University of Campinas, Brazil
Enrollment
20
Locations
1
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The current study sought to determine the reliability of the rehabilitation protocol using the labial commissure angle (LCA) as an indicator of both muscle tonus and therapeutic success. The investigators hypothesized that this measurement would provide objective data regarding the efficacy of rehabilitation for these challenging patients.

Detailed Description

CONTEXT AND OBJECTIVE: In cases of peripheral facial paralysis (PFP), diminished facial movements and their resultant cosmetic sequelae may have significant emotional repercussions, in addition to producing pronounced functional deficits. Abnormal muscle proprioception and deviation of the nasal-labial filter may also interfere with articulation of the labiodental and bilabial phonemes, thus diminishing speech intelligibility. In relation to stomatognathic functions, weakened labial occlusion decreases intraoral pressure, thereby hindering liquid retention in the buccal cavity and giving rise to vestibular stasis on the paralyzed side. The aim of this study was to evaluate the reliability of the labial commissure angle (LCA) as an anthropometric marker for objectively assessing changes in facial muscle tonus.

Registry
clinicaltrials.gov
Start Date
January 2005
End Date
February 2006
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Campinas, Brazil

Eligibility Criteria

Inclusion Criteria

  • age range between 20 and 70 years
  • incomplete PFP (Degree IV)
  • integral facial nerve (FN)

Exclusion Criteria

  • systemic disease
  • potentially aggravating the PFP (neurological, degenerative, endocrinological)

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials